Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Not Over Yet: Eisai And Lilly To Appeal England’s ‘Flawed’ Refusal To Fund Leqembi And Kisunla
19 Jun 2025
•
By
Neena Brizmohun
Patients in England will not be able to access the Alzheimer's treatments Leqembi and Kisunla via the NHS
(Shutterstock)
More from Health Technology Assessment
More from